PCSK9 and Hypercholesterolemia: Monogenic forms of hypercholesterolaemia have implicated key genes in the LDL-cholesterol transport pathway, including PCSK9, with PCSK9 monoclonal antibodies evolocumab and alirocumab now indicated for treatment of common hyperlipidaemia.